JP7471486B2 - 血糖値較正方法 - Google Patents
血糖値較正方法 Download PDFInfo
- Publication number
- JP7471486B2 JP7471486B2 JP2023040890A JP2023040890A JP7471486B2 JP 7471486 B2 JP7471486 B2 JP 7471486B2 JP 2023040890 A JP2023040890 A JP 2023040890A JP 2023040890 A JP2023040890 A JP 2023040890A JP 7471486 B2 JP7471486 B2 JP 7471486B2
- Authority
- JP
- Japan
- Prior art keywords
- blood glucose
- calibration
- input
- reference value
- glucose level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008280 blood Substances 0.000 title claims description 348
- 210000004369 blood Anatomy 0.000 title claims description 348
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims description 344
- 239000008103 glucose Substances 0.000 title claims description 344
- 238000000034 method Methods 0.000 title claims description 35
- 238000012544 monitoring process Methods 0.000 claims description 9
- 238000004891 communication Methods 0.000 description 20
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 238000005259 measurement Methods 0.000 description 11
- 238000010586 diagram Methods 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 4
- 230000002218 hypoglycaemic effect Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 101100313728 Vitis vinifera VINST1 gene Proteins 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/155—Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6844—Monitoring or controlling distance between sensor and tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
- A61B2560/0238—Means for recording calibration data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0266—Operational features for monitoring or limiting apparatus function
Description
糖尿病は現代人にたくさん発生される慢性疾患で国内の場合全体人口の5%に該当する200万人以上に至る。
Claims (6)
- 使用者端末機で血糖値を較正する方法であって、
前記使用者端末機が、較正周期に血糖測定装置で測定した血糖値を抽出する段階と、
前記使用者端末機が、前記較正周期に入力可能な基準値範囲を計算する段階であって、前記較正周期に測定した前記血糖値に前記基準値範囲の上限値を計算するのに利用される第1の臨界範囲を加えた上限基準値と、前記較正周期に測定した前記血糖値から前記基準値範囲の下限値を計算するのに利用される第2の臨界範囲を差し引いた下限基準値と、に基づいて前記基準値範囲を計算する段階と、
前記使用者端末機が、前記較正周期に入力することができる基準値を前記基準値範囲に限定してスクロールする入力窓を含む使用者インターフェースを生成する段階と、
を含む
血糖値較正方法。 - 請求項1に記載の血糖値較正方法であって、
前記使用者インターフェースを通じて前記基準値範囲内で前記基準値が入力される場合、入力された前記基準値から生成される較正情報を使用する第1較正モードで較正を遂行する段階
をさらに含む、
血糖値較正方法。 - 請求項1に記載の血糖値較正方法であって、
入力された使用者命令に従って前記較正周期の基準値を使用者が直接入力するための第2使用者インターフェースを生成する段階と、
前記第2使用者インターフェースを通じてお互いに異なる時刻に測定された複数の基準値が入力される場合、前記複数の基準値から生成される較正情報を使用する第2較正モードで較正を遂行する段階と、
をさらに含む、
血糖値較正方法。 - 請求項1に記載の血糖値較正方法であって、
前記使用者インターフェースを通じて入力される前記較正周期の基準値が前記基準値範囲を脱するかを判断する段階と、
入力された前記基準値が前記基準値範囲を脱するかの如何によって較正モードを相異に選択して較正を遂行する段階と、
をさらに含む
血糖値較正方法。 - 請求項4に記載の血糖値較正方法であって、
前記較正モードは、
入力された前記基準値が前記基準値範囲である場合、前記較正周期に入力された前記基準値から生成される較正情報を使用する第1較正モードと、
入力された前記基準値が前記基準値範囲を脱した場合、前記較正周期に入力される複数の基準値から生成される較正情報を生成する第2較正モードと、
を含む
血糖値較正方法。 - 請求項3又は5に記載の血糖値較正方法であって、
前記第2較正モードで複数の基準値が入力される時刻をモニタリングして、
前記複数の基準値が入力される時間差が既設定した臨界時間差を超過する場合、使用者にアラームを提供する
血糖値較正方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2019-0153096 | 2019-11-26 | ||
KR1020190153096A KR102445697B1 (ko) | 2019-11-26 | 2019-11-26 | 연속혈당측정시스템에서 혈당값을 교정하는 방법 |
JP2021563727A JP7247370B2 (ja) | 2019-11-26 | 2020-08-19 | 連続血糖測定システムで血糖値を較正する方法 |
PCT/KR2020/011006 WO2021107335A1 (ko) | 2019-11-26 | 2020-08-19 | 연속혈당측정시스템에서 혈당값을 교정하는 방법 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021563727A Division JP7247370B2 (ja) | 2019-11-26 | 2020-08-19 | 連続血糖測定システムで血糖値を較正する方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023063494A JP2023063494A (ja) | 2023-05-09 |
JP7471486B2 true JP7471486B2 (ja) | 2024-04-19 |
Family
ID=76129732
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021563727A Active JP7247370B2 (ja) | 2019-11-26 | 2020-08-19 | 連続血糖測定システムで血糖値を較正する方法 |
JP2023040890A Active JP7471486B2 (ja) | 2019-11-26 | 2023-03-15 | 血糖値較正方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021563727A Active JP7247370B2 (ja) | 2019-11-26 | 2020-08-19 | 連続血糖測定システムで血糖値を較正する方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220160266A1 (ja) |
EP (1) | EP3932310A4 (ja) |
JP (2) | JP7247370B2 (ja) |
KR (3) | KR102445697B1 (ja) |
AU (2) | AU2020393447B2 (ja) |
WO (1) | WO2021107335A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102438798B1 (ko) | 2021-12-22 | 2022-09-01 | 제일기술(주) | 연속혈당측정장치 |
KR20230100948A (ko) * | 2021-12-29 | 2023-07-06 | 주식회사 아이센스 | 교정 알람 방법 |
KR20230103396A (ko) * | 2021-12-31 | 2023-07-07 | 주식회사 아이센스 | 교정 알람 방법 |
KR20230110987A (ko) * | 2022-01-17 | 2023-07-25 | 주식회사 아이센스 | 연속생체 정보 측정 시스템에서 생체 신호를 교정하는 방법 |
KR20230165066A (ko) * | 2022-05-26 | 2023-12-05 | 주식회사 아이센스 | 생체 정보 측정 시스템에서 생체값의 안정화 여부에 따라 생체값을 교정하는 방법 |
CN115670448B (zh) * | 2022-10-13 | 2023-09-19 | 安徽医科大学第二附属医院 | 一种血糖连续监测设备及系统 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003508746A (ja) | 1999-08-31 | 2003-03-04 | シーエムイー テレメトリックス インク. | 分光装置を較正する方法 |
JP2008096448A (ja) | 2003-08-01 | 2008-04-24 | Dexcom Inc | アナライトセンサデータの処理 |
JP2011062335A (ja) | 2009-09-17 | 2011-03-31 | Panasonic Electric Works Co Ltd | 血糖値モニタリング装置 |
US20110184268A1 (en) | 2010-01-22 | 2011-07-28 | Abbott Diabetes Care Inc. | Method, Device and System for Providing Analyte Sensor Calibration |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8323195B2 (en) * | 2008-12-31 | 2012-12-04 | Panasonic Corporation | Blood glucose measurement system |
US8744783B2 (en) * | 2009-08-27 | 2014-06-03 | The United States Of America As Represented By The Secretary Of The Navy | System and method for measuring power generated during legged locomotion |
JP5462776B2 (ja) * | 2010-01-19 | 2014-04-02 | アークレイ株式会社 | 測定装置及び測定方法 |
WO2012058337A2 (en) * | 2010-10-27 | 2012-05-03 | Dexcom, Inc. | Continuous analyte monitor data recording device operable in a blinded mode |
US9492118B1 (en) * | 2013-06-28 | 2016-11-15 | Life Sciences Llc | Pre-treatment process for electrochemical amperometric sensor |
CA2953577A1 (en) * | 2014-09-22 | 2016-03-31 | Dexcom, Inc. | System and method for mode switching |
KR102381045B1 (ko) * | 2017-03-17 | 2022-03-31 | 삼성전자주식회사 | 전자 장치 및 그 제어 방법 |
KR101975198B1 (ko) * | 2017-07-24 | 2019-08-28 | 최규동 | 하이브리드 연속혈당측정 시스템 |
KR102430437B1 (ko) * | 2017-11-20 | 2022-08-09 | 삼성전자주식회사 | 혈당 측정기, 혈당 측정 시스템 및 그 혈당 측정기를 이용한 혈당의 측정 방법 |
-
2019
- 2019-11-26 KR KR1020190153096A patent/KR102445697B1/ko active IP Right Grant
-
2020
- 2020-08-19 US US17/602,284 patent/US20220160266A1/en active Pending
- 2020-08-19 AU AU2020393447A patent/AU2020393447B2/en active Active
- 2020-08-19 EP EP20892276.5A patent/EP3932310A4/en active Pending
- 2020-08-19 WO PCT/KR2020/011006 patent/WO2021107335A1/ko unknown
- 2020-08-19 JP JP2021563727A patent/JP7247370B2/ja active Active
-
2022
- 2022-09-15 KR KR1020220116356A patent/KR102535394B1/ko active IP Right Grant
- 2022-12-27 AU AU2022291652A patent/AU2022291652A1/en active Pending
-
2023
- 2023-03-15 JP JP2023040890A patent/JP7471486B2/ja active Active
- 2023-05-17 KR KR1020230063998A patent/KR20230074099A/ko not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003508746A (ja) | 1999-08-31 | 2003-03-04 | シーエムイー テレメトリックス インク. | 分光装置を較正する方法 |
JP2008096448A (ja) | 2003-08-01 | 2008-04-24 | Dexcom Inc | アナライトセンサデータの処理 |
JP2011062335A (ja) | 2009-09-17 | 2011-03-31 | Panasonic Electric Works Co Ltd | 血糖値モニタリング装置 |
US20110184268A1 (en) | 2010-01-22 | 2011-07-28 | Abbott Diabetes Care Inc. | Method, Device and System for Providing Analyte Sensor Calibration |
Also Published As
Publication number | Publication date |
---|---|
AU2022291652A1 (en) | 2023-02-02 |
JP2022530511A (ja) | 2022-06-29 |
KR20210064651A (ko) | 2021-06-03 |
US20220160266A1 (en) | 2022-05-26 |
JP7247370B2 (ja) | 2023-03-28 |
KR102535394B1 (ko) | 2023-05-26 |
KR20220130646A (ko) | 2022-09-27 |
JP2023063494A (ja) | 2023-05-09 |
EP3932310A4 (en) | 2022-12-14 |
KR20230074099A (ko) | 2023-05-26 |
AU2020393447A1 (en) | 2021-10-14 |
AU2020393447B2 (en) | 2022-10-13 |
EP3932310A1 (en) | 2022-01-05 |
WO2021107335A1 (ko) | 2021-06-03 |
KR102445697B1 (ko) | 2022-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7471486B2 (ja) | 血糖値較正方法 | |
US20200152335A1 (en) | Method for the Detection and Handling of Hypoglycemia | |
RU2721878C2 (ru) | Способы и системы для анализа данных о содержании глюкозы, измеренных у больного диабетом | |
US20200000384A1 (en) | Glycemic health metric determination and application | |
EP2873015B1 (en) | Insulin dosage assessment and recommendation system | |
US20160354019A1 (en) | Glycemic health metric determination and application | |
JP7397843B2 (ja) | 生理学的パラメータに対する動的グルコースプロファイル応答のシステム、デバイス及び方法 | |
EP2051620B1 (en) | Method and device for monitoring a physiological parameter | |
CA3042837A1 (en) | A computer-implemented method and a portable device for analyzing glucose monitoring data indicative of a glucose level in a bodily fluid, and a computer program product | |
JP7324359B2 (ja) | 連続血糖測定システムで生体情報を紛失なしに送受信する方法 | |
JP2024026379A (ja) | 連続血糖測定システムにおける較正情報を管理する方法 | |
KR102246064B1 (ko) | 생체 정보의 표시 방법 | |
KR101591072B1 (ko) | 개인화된 저혈당 수치를 이용한 혈당 관리 방법 | |
CA3039212A1 (en) | Method for emphasizing analyte values during a therapeutic window | |
KR20230103396A (ko) | 교정 알람 방법 | |
KR20230100948A (ko) | 교정 알람 방법 | |
US20220361778A1 (en) | Data-Stream Bridging for Sensor Transitions | |
CN117222356A (zh) | 用于传感器过渡的数据流桥接 | |
KR20230110987A (ko) | 연속생체 정보 측정 시스템에서 생체 신호를 교정하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230315 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240109 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240328 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240402 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240409 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7471486 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |